| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| DGACDISCIPLINED GROWTH ACQUISITION Corp | $219.97M | — | — | — | — | $696.29K | — | AI pending |
| CHRSCoherus Oncology, Inc. | $220.16M | — | $42.17M | +59.8% | $168.02M | $82.92M | $73.66M | AI pending |
| CRDLCardiol Therapeutics Inc. | $220.21M | — | CA$78.76K | — | -CA$31.64M | CA$21.42M | — | AI pending |
| BCARD. Boral ARC Acquisition I Corp. | $220.25M | 26.6× | — | — | — | $0 | — | AI pending |
| NBPNovaBridge Biosciences | $220.38M | — | $632K | +140.7% | -$207.73M | $210.63M | $4.22M | AI pending |
| SZZLSizzle Acquisition Corp. II | $220.62M | 41.5× | — | — | — | $340.15K | — | AI pending |
| ESOAEnergy Services of America CORP | $220.83M | 19.6× | $411M | +16.8% | — | $14.68M | $45.33M | AI pending |
| ONCH1RT Acquisition Corp. | $222.09M | 38.5× | — | — | — | $36.2K | — | AI pending |
| CFBKCf Bankshares Inc. | $223.53M | 11.9× | $60.95M | +17.6% | $17.54M | $253.1M | $29.46M | AI pending |
| SUPXSuperX AI Technology Ltd | $224.28M | — | $3.6M | +23.9% | -$21.21M | $17.21M | $575.96K | AI pending |
| PPIHPerma-Pipe International Holdings, Inc. | $224.35M | 16.3× | $210.93M | +33.2% | $17.04M | $28.3M | $29.57M | AI pending |
| UTMDUtah Medical Products Inc | $225.1M | 21.5× | $38.52M | -5.8% | $11.29M | $87.53M | $195K | AI pending |
| LXLexinFintech Holdings Ltd. | $225.47M | 1.2× | CN¥8.58B | -10.0% | CN¥1.68B | CN¥2.16B | CN¥746.02M | AI pending |
| IMUXImmunic, Inc. | $225.61M | — | — | — | — | $155.1M | — | AI pending |
| MPAAMotorcar Parts Of America Inc | $226.06M | — | $789.81M | +4.3% | $12.39M | $19.12M | $28.79M | AI pending |
| FORRForrester Research, Inc. | $226.32M | — | $396.89M | -8.2% | -$119.36M | $59.52M | $35M | AI pending |
| TARAProtara Therapeutics, Inc. | $226.63M | — | $2.95M | — | -$3.34M | $17.08M | $0 | AI pending |
| ALOTAstroNova, Inc. | $226.65M | — | $150.52M | -0.5% | -$2.38M | $4.68M | $20.51M | AI pending |
| EFTYEtoiles Capital Group Co., Ltd | $226.95M | — | $3.22M | +27.6% | -$153.66K | $5.43M | — | AI pending |
| RNAAtrium Therapeutics, Inc. | $227.16M | — | — | — | — | $72.33M | — | AI pending |